ArticleScientific reports2026
TmKayak functions as an effector of Jun N-terminal kinase pathway to modulate immune responses in Tenebrio molitor.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The c-Jun N-terminal kinase (JNK) signaling pathway plays a critical role in insect stress responses and immunity; however, its downstream transcriptional mechanisms remain poorly understood in coleopteran species. The kayak gene, a Fos homolog that functions as a JNK-responsive transcription factor, has been well studied in Drosophila melanogaster, but its role in beetles remains unexplored. In this study, we examined the functional role of TmKayak in the immune response of Tenebrio molitor using RNA interference. Upon TmKayak knockdown, we assessed the expression patterns of 15 antimicrobial peptide (AMP) genes in four immune-relevant tissues including fat body, gut, Malpighian tubules, and integument following three distinct microorganisms injection with Escherichia coli, Staphylococcus aureus, or Candida albicans. In all three injection models, E. coli, S. aureus, and C. albicans, a noticeable reduction in viability was observed in larvae injected with dsTmkayak compared to the dsEGFP control group. Notably, quantitative real-time PCR analysis revealed that TmKayak knockdown resulted in broad suppression of AMP expression, particularly in response to E. coli and S. aureus. In contrast, a relatively mild regulatory effect was observed following injection with C. albicans. Collectively, these findings identify TmKayak as a key transcriptional effector of the JNK pathway and contribute to a deeper understanding of innate immune regulation in T. molitor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.